Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Osteogenesis imperfecta, but which one?].

P Guibaud1

  • 1Service de pédiatrie et génétique, Hôpital Debrousse, Lyon, France.

Pediatrie
|January 1, 1990
PubMed
Summary
This summary is machine-generated.

Osteogenesis imperfecta, a group of inherited collagen disorders, presents diverse clinical and genetic features. Understanding these variations, classified by Sillence, aids in managing the condition, often with dominant inheritance.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Outcome of 27 patients with Hurler's syndrome transplanted from either related or unrelated haematopoietic stem cell sources.

Bone marrow transplantation·2003
Same author

[Persistent hyperplastic primary vitreous syndrome in a girl with Aicardi syndrome].

Journal francais d'ophtalmologie·2000
Same author

Renal carcinoma in a patient with glycogen storage disease Ib receiving long-term granulocyte colony-stimulating factor therapy.

Journal of pediatric hematology/oncology·2000
Same author

Mutations in the pterin-4alpha-carbinolamine dehydratase (PCBD) gene cause a benign form of hyperphenylalaninemia.

Human genetics·1998
Same author

Follow-up of nine patients with Hurler syndrome after bone marrow transplantation.

The Journal of pediatrics·1998
Same author

[Study of plasma acylcarnitines using tandem mass spectrometry. Application to the diagnosis of metabolism hereditary diseases].

Archives de pediatrie : organe officiel de la Societe francaise de pediatrie·1997
Same journal

[Colonic atresia: report of a case].

Pediatrie·1993
Same journal

[Psychological aspects of bone marrow donation in donor brothers and sisters in bone marrow transplantation].

Pediatrie·1993
Same journal

[Lethargy in the course of treatment with ranitidine in a newborn infant].

Pediatrie·1993
Same journal

[Delayed detection of hip dislocation: is the physician to blame?].

Pediatrie·1993
Same journal

[Renal tubular acidosis in children].

Pediatrie·1993
Same journal

[CD23: structures, functions and practical perspectives in allergy reactions].

Pediatrie·1993
See all related articles

Area of Science:

  • Genetics
  • Biochemistry
  • Orthopedics

Context:

  • Osteogenesis imperfecta (OI) is a group of inherited connective tissue disorders.
  • These disorders primarily affect type I collagen and the extracellular matrix.
  • The heterogeneity of OI encompasses molecular, clinical, and genetic aspects.

Purpose:

  • To classify and understand the heterogeneity of Osteogenesis imperfecta.
  • To provide a basis for clinical management through biochemical and genetic analysis.
  • To elucidate the genetic transmission patterns of OI.

Summary:

  • Osteogenesis imperfecta (OI) is characterized by its heterogeneous nature, affecting type I collagen and the matrix.
  • Classification systems, such as the Sillence classification, distinguish five clinical situations for management.

Related Experiment Videos

  • Biochemical studies reveal the molecular basis for this heterogeneity and confirm autosomal dominant inheritance in most cases, including severe forms.

    • Impact:

    • Provides a framework for diagnosing and managing diverse Osteogenesis imperfecta cases.
    • Enhances understanding of the molecular and genetic underpinnings of collagen disorders.
    • Facilitates genetic counseling and risk assessment for affected families.